atezolizumab,nivolumab,ipilimumab,Pembrolizumab
merck,roche,bms
['keytruda', 'kidney cancer', 'roche,(-broche),(-rocheter)', 'merck', 'bristol']
three bristol myers squibb and roche i-o flops in adjuvant kidney cancer may not be that good news to merck's keytruda. #esmo22 
Tweets from the Fierce Life Sciences editorial team